Literature DB >> 17182845

Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway.

Martha B Johnson1, Juxing Chen, Nicholas Murchison, Frank A Green, Caroline A Enns.   

Abstract

Transferrin receptor 2 (TfR2) is a homologue of transferrin receptor 1 (TfR1), the protein that delivers iron to cells through receptor-mediated endocytosis of diferric transferrin (Fe(2)Tf). TfR2 also binds Fe(2)Tf, but it seems to function primarily in the regulation of systemic iron homeostasis. In contrast to TfR1, the trafficking of TfR2 within the cell has not been extensively characterized. Previously, we showed that Fe(2)Tf increases TfR2 stability, suggesting that trafficking of TfR2 may be regulated by interaction with its ligand. In the present study, therefore, we sought to identify the mode of TfR2 degradation, to characterize TfR2 trafficking, and to determine how Fe(2)Tf stabilizes TfR2. Stabilization of TfR2 by bafilomycin implies that TfR2 traffics to the lysosome for degradation. Confocal microscopy reveals that treatment of cells with Fe(2)Tf increases the fraction of TfR2 localizing to recycling endosomes and decreases the fraction of TfR2 localizing to late endosomes. Mutational analysis of TfR2 shows that the mutation G679A, which blocks TfR2 binding to Fe(2)Tf, increases the rate of receptor turnover and prevents stabilization by Fe(2)Tf, indicating a direct role of Fe(2)Tf in TfR2 stabilization. The mutation Y23A in the cytoplasmic domain of TfR2 inhibits its internalization and degradation, implicating YQRV as an endocytic motif.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17182845      PMCID: PMC1805103          DOI: 10.1091/mbc.e06-09-0798

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  60 in total

1.  Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE.

Authors:  A P West; M J Bennett; V M Sellers; N C Andrews; C A Enns; P J Bjorkman
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

2.  Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments.

Authors:  P Chavrier; R G Parton; H P Hauri; K Simons; M Zerial
Journal:  Cell       Date:  1990-07-27       Impact factor: 41.582

3.  Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis.

Authors:  R E Fleming; M C Migas; C C Holden; A Waheed; R S Britton; S Tomatsu; B R Bacon; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

4.  Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo.

Authors:  H Kawabata; R S Germain; P T Vuong; T Nakamaki; J W Said; H P Koeffler
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Regulation of transferrin receptor 2 protein levels by transferrin.

Authors:  Aeisha Robb; Marianne Wessling-Resnick
Journal:  Blood       Date:  2004-08-19       Impact factor: 22.113

7.  Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells.

Authors:  E J Bowman; A Siebers; K Altendorf
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.

Authors:  Antonella Roetto; George Papanikolaou; Marianna Politou; Federica Alberti; Domenico Girelli; John Christakis; Dimitris Loukopoulos; Clara Camaschella
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

9.  Hepcidin is decreased in TFR2 hemochromatosis.

Authors:  Elizabeta Nemeth; Antonella Roetto; Giovanni Garozzo; Tomas Ganz; Clara Camaschella
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

Review 10.  The Golgi complex: in vitro veritas?

Authors:  I Mellman; K Simons
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

View more
  45 in total

Review 1.  Forging a field: the golden age of iron biology.

Authors:  Nancy C Andrews
Journal:  Blood       Date:  2008-07-15       Impact factor: 22.113

Review 2.  The endosomal system of plants: charting new and familiar territories.

Authors:  David G Robinson; Liwen Jiang; Karin Schumacher
Journal:  Plant Physiol       Date:  2008-08       Impact factor: 8.340

Review 3.  Liver iron sensing and body iron homeostasis.

Authors:  Chia-Yu Wang; Jodie L Babitt
Journal:  Blood       Date:  2018-11-06       Impact factor: 22.113

4.  CD81 promotes both the degradation of transferrin receptor 2 (TfR2) and the Tfr2-mediated maintenance of hepcidin expression.

Authors:  Juxing Chen; Caroline A Enns
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

Review 5.  The pathophysiology and pharmacology of hepcidin.

Authors:  Piotr Ruchala; Elizabeta Nemeth
Journal:  Trends Pharmacol Sci       Date:  2014-02-17       Impact factor: 14.819

Review 6.  The role of hepcidin in iron metabolism.

Authors:  Elizabeta Nemeth; Tomas Ganz
Journal:  Acta Haematol       Date:  2009-11-10       Impact factor: 2.195

7.  Actin dynamics regulate multiple endosomal steps during Kaposi's sarcoma-associated herpesvirus entry and trafficking in endothelial cells.

Authors:  Whitney Greene; Shou-Jiang Gao
Journal:  PLoS Pathog       Date:  2009-07-10       Impact factor: 6.823

8.  Cellular microvesicle pathways can be targeted to transfer genetic information between non-immune cells.

Authors:  Amy M Skinner; S Lee O'Neill; Peter Kurre
Journal:  PLoS One       Date:  2009-07-13       Impact factor: 3.240

Review 9.  A general map of iron metabolism and tissue-specific subnetworks.

Authors:  Valerie Hower; Pedro Mendes; Frank M Torti; Reinhard Laubenbacher; Steven Akman; Vladmir Shulaev; Suzy V Torti
Journal:  Mol Biosyst       Date:  2009-03-06

10.  Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias.

Authors:  Elizabeta Nemeth
Journal:  Adv Hematol       Date:  2009-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.